A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.
Condition(s):PainLast Updated:January 19, 2011Completed
Hide Studies Not Open or Pending
Condition(s):PainLast Updated:January 19, 2011Completed
Condition(s):Chronic PainLast Updated:July 23, 2018Completed
Condition(s):Complex Regional Pain SyndromesLast Updated:March 15, 2024Not yet recruiting
Condition(s):Complex Regional Pain SyndromesLast Updated:February 24, 2020Withdrawn
Condition(s):Complex Regional Pain Syndrome, Type ILast Updated:May 9, 2018Completed
Condition(s):CRPS (Complex Regional Pain Syndromes)Last Updated:October 13, 2008Completed
Condition(s):CRPS (Complex Regional Pain Syndromes)Last Updated:October 13, 2008Completed
Condition(s):Complex Regional Pain Syndrome; Reflex Sympathetic DystrophyLast Updated:March 23, 2018Unknown status
Condition(s):Ankle FractureLast Updated:April 19, 2011Unknown status
Condition(s):Transcranial Magnetic Stimulation; Complex Regional Pain Syndrome of Upper Limb (Disorder)Last Updated:May 31, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.